Relmada Therapeutics, Inc. (RLMD)
4.52
+0.45
(+11.06%)
USD |
NASDAQ |
Sep 11, 16:00
4.62
+0.10
(+2.21%)
After-Hours: 20:00
Relmada Therapeutics Total Liabilities (Quarterly) : 12.50M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.50M |
| March 31, 2026 | 16.63M |
| December 31, 2025 | 7.492M |
| September 30, 2025 | 5.411M |
| June 30, 2025 | 5.167M |
| March 31, 2025 | 5.239M |
| December 31, 2024 | 10.30M |
| September 30, 2024 | 8.099M |
| June 30, 2024 | 9.537M |
| March 31, 2024 | 12.36M |
| December 31, 2023 | 12.19M |
| September 30, 2023 | 8.422M |
| June 30, 2023 | 10.70M |
| March 31, 2023 | 10.10M |
| December 31, 2022 | 12.47M |
| September 30, 2022 | 20.78M |
| June 30, 2022 | 18.92M |
| March 31, 2022 | 15.41M |
| December 31, 2021 | 15.06M |
| September 30, 2021 | 18.25M |
| June 30, 2021 | 13.92M |
| March 31, 2021 | 12.72M |
| December 31, 2020 | 12.60M |
| September 30, 2020 | 3.390M |
| June 30, 2020 | 2.326M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.261M |
| June 30, 2019 | 2.606M |
| March 31, 2019 | 2.130M |
| December 31, 2018 | 1.864M |
| September 30, 2018 | 10.30M |
| June 30, 2018 | 8.561M |
| March 31, 2018 | 7.112M |
| December 31, 2017 | 5.853M |
| September 30, 2017 | 4.149M |
| June 30, 2017 | 1.377M |
| March 31, 2017 | 1.368M |
| December 31, 2016 | 1.550M |
| September 30, 2016 | 2.348M |
| June 30, 2016 | 3.202M |
| March 31, 2016 | 2.513M |
| December 31, 2015 | 4.840M |
| September 30, 2015 | 6.649M |
| June 30, 2015 | 15.58M |
| March 31, 2015 | 25.36M |
| December 31, 2014 | 28.20M |
| September 30, 2014 | 48.57M |
| August 31, 2014 | |
| May 31, 2014 | |
| February 28, 2014 | 0.0412M |
| September 30, 2013 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 219.06M |
| Shareholders Equity (Quarterly) | 206.56M |
| Current Ratio | 29.52 |